Pretraga

Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1046217

Drug–drug interaction trials incompletely described drug interventions in ClinicalTrials.gov and published articles: an observational study

Jurić, Diana; Bolić, Adriana; Pranić, Shelly; Marušić, Ana
Drug–drug interaction trials incompletely described drug interventions in ClinicalTrials.gov and published articles: an observational study // Journal of clinical epidemiology, 117 (2020), 126-137 doi:10.1016/j.jclinepi.2019.10.002 (međunarodna recenzija, članak, znanstveni)

CROSBI ID: 1046217 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Drug–drug interaction trials incompletely described drug interventions in ClinicalTrials.gov and published articles: an observational study

Autori
Jurić, Diana ; Bolić, Adriana ; Pranić, Shelly ; Marušić, Ana

Izvornik
Journal of clinical epidemiology (0895-4356) 117 (2020); 126-137

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Description of drug intervention as topic ; Drug interaction ; Databases ; Reporting ; Bias ; Transparency ; Trial registration

Sažetak
OBJECTIVES: The aim of the study was to evaluate the completeness of intervention description in ClinicalTrials.gov and corresponding journal articles for registered and published drug-drug interaction (DDI) trials because complete and transparent description of interventions is particularly important for DDI. STUDY DESIGN AND SETTING: Observational study of completed interventional trials on DDIs with up to two drugs within the Intervention registration element in ClinicalTrials.gov until October 2015. We used the Template for Intervention Description and Replication items to assess the quality of intervention description in both ClinicalTrials.gov Descriptive Information section and matching publications. Corresponding articles were identified in March 2019. RESULTS: The description of 1, 180 drug interventions registered for 642 DDI trials mostly lacked information on the intervention provider (99.7%), adherence strategies (99.2%), procedure (83.8%), location (71.3%), and dosage form (60.7%). Generic name (82.5%), dose (70.8%), and duration of administration (65.6%) were most frequently reported. Among 51 trials that had data reported both in ClinicalTrials.gov and publication, 60.8% were in phase 1. Less than half of 96 interventions had clear and matching description of dosage form, procedure, and route of administration in both sources. CONCLUSION: DDI trials did not sufficiently report components required for complete intervention description. Further improvements in ClinicalTrials.gov registration requirements, including phase 1 trials, and more stringent publishing requirements for essential data on drug interventions, are needed to prevent patient risk in clinical practice regarding concomitant medication use.

Izvorni jezik
Engleski



POVEZANOST RADA

Projekti:
HRZZ projekt IP-2014-09-7672 ‘‘Professionalism in Health Care’’

Ustanove:
Medicinski fakultet, Split

Profili:

Avatar Url Shelly Pranić (autor)

Avatar Url Ana Marušić (autor)

Avatar Url Diana Gujinović (autor)

Poveznice na cjeloviti tekst rada:

Pristup cjelovitom tekstu rada doi www.sciencedirect.com

Citiraj ovu publikaciju:

Jurić, Diana; Bolić, Adriana; Pranić, Shelly; Marušić, Ana
Drug–drug interaction trials incompletely described drug interventions in ClinicalTrials.gov and published articles: an observational study // Journal of clinical epidemiology, 117 (2020), 126-137 doi:10.1016/j.jclinepi.2019.10.002 (međunarodna recenzija, članak, znanstveni)
Jurić, D., Bolić, A., Pranić, S. & Marušić, A. (2020) Drug–drug interaction trials incompletely described drug interventions in ClinicalTrials.gov and published articles: an observational study. Journal of clinical epidemiology, 117, 126-137 doi:10.1016/j.jclinepi.2019.10.002.
@article{article, author = {Juri\'{c}, Diana and Boli\'{c}, Adriana and Prani\'{c}, Shelly and Maru\v{s}i\'{c}, Ana}, year = {2020}, pages = {126-137}, DOI = {10.1016/j.jclinepi.2019.10.002}, keywords = {Description of drug intervention as topic, Drug interaction, Databases, Reporting, Bias, Transparency, Trial registration}, journal = {Journal of clinical epidemiology}, doi = {10.1016/j.jclinepi.2019.10.002}, volume = {117}, issn = {0895-4356}, title = {Drug–drug interaction trials incompletely described drug interventions in ClinicalTrials.gov and published articles: an observational study}, keyword = {Description of drug intervention as topic, Drug interaction, Databases, Reporting, Bias, Transparency, Trial registration} }
@article{article, author = {Juri\'{c}, Diana and Boli\'{c}, Adriana and Prani\'{c}, Shelly and Maru\v{s}i\'{c}, Ana}, year = {2020}, pages = {126-137}, DOI = {10.1016/j.jclinepi.2019.10.002}, keywords = {Description of drug intervention as topic, Drug interaction, Databases, Reporting, Bias, Transparency, Trial registration}, journal = {Journal of clinical epidemiology}, doi = {10.1016/j.jclinepi.2019.10.002}, volume = {117}, issn = {0895-4356}, title = {Drug–drug interaction trials incompletely described drug interventions in ClinicalTrials.gov and published articles: an observational study}, keyword = {Description of drug intervention as topic, Drug interaction, Databases, Reporting, Bias, Transparency, Trial registration} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE

Citati:

    Altmetrijski pokazatelji:


    Podijeli:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font
    CROSBI koristi kolačiće (cookies) kako bi poboljšao funkcionalnost stranice.